Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;50(12):2041-2054.
doi: 10.1002/eji.201948501. Epub 2020 Jul 26.

Cross-presentation of dead-cell-associated antigens by DNGR-1+ dendritic cells contributes to chronic allograft rejection in mice

Affiliations
Free article

Cross-presentation of dead-cell-associated antigens by DNGR-1+ dendritic cells contributes to chronic allograft rejection in mice

Saidou Balam et al. Eur J Immunol. 2020 Dec.
Free article

Abstract

The purpose of this study was to elucidate whether DC NK lectin group receptor-1 (DNGR-1)-dependent cross-presentation of dead-cell-associated antigens occurs after transplantation and contributes to CD8+ T cell responses, chronic allograft rejection (CAR), and fibrosis. BALB/c or C57BL/6 hearts were heterotopically transplanted into WT, Clec9a-/- , or Batf3-/- recipient C57BL/6 mice. Allografts were analyzed for cell infiltration, CD8+ T cell activation, fibrogenesis, and CAR using immunohistochemistry, Western blot, qRT2 -PCR, and flow cytometry. Allografts displayed infiltration by recipient DNGR-1+ DCs, signs of CAR, and fibrosis. Allografts in Clec9a-/- recipients showed reduced CAR (p < 0.0001), fibrosis (P = 0.0137), CD8+ cell infiltration (P < 0.0001), and effector cytokine levels compared to WT recipients. Batf3-deficiency greatly reduced DNGR-1+ DC-infiltration, CAR (P < 0.0001), and fibrosis (P = 0.0382). CD8 cells infiltrating allografts of cytochrome C treated recipients, showed reduced production of CD8 effector cytokines (P < 0.05). Further, alloreactive CD8+ T cell response in indirect pathway IFN-γ ELISPOT was reduced in Clec9a-/- recipient mice (P = 0.0283). Blockade of DNGR-1 by antibody, similar to genetic elimination of the receptor, reduced CAR (P = 0.0003), fibrosis (P = 0.0273), infiltration of CD8+ cells (p = 0.0006), and effector cytokine levels. DNGR-1-dependent alloantigen cross-presentation by DNGR-1+ DCs induces alloreactive CD8+ cells that induce CAR and fibrosis. Antibody against DNGR-1 can block this process and prevent CAR and fibrosis.

Keywords: CD8+ T cells; DNGR-1; cDC1; cross-presentation; transplantation.

PubMed Disclaimer

References

    1. Racusen, L. C., Solez, K. and Colvin, R., Fibrosis and atrophy in the renal allograft: interim report and new directions. Am. J. Transplant. 2002. 2: 203-206.
    1. Brunner, S. M., Schiechl, G., Kesselring, R., Martin, M., Balam, S., Schlitt, H. J., Geissler, E. K. et al., IL-13 signaling via IL-13Ralpha2 triggers TGF-beta1-dependent allograft fibrosis. Transplant. Res. 2013. 2: 16.
    1. Pichler, M., Rainer, P. P., Schauer, S. and Hoefler G., Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J. Am. Coll. Cardiol. 2012. 59: 1008-1016.
    1. Huibers, M., De Jonge, N., Van Kuik, J., Siera-De Koning, E., Van Wichen, D., Dullens, H., Schipper, M. et al., Intimal fibrosis in human cardiac allograft vasculopathy. Transpl. Immunol. 2011. 25: 124-132.
    1. Brunner, S. M., Schiechl, G., Falk, W., Schlitt, H. J., Geissler, E. K. and Fichtner-Feigl, S., Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl. Int. 2011. 24: 1027-1039.

Publication types

LinkOut - more resources